A clinical study of A. baumannii infection patients treated with imipenem-cilastatin and ampicillin-sulbactam
- VernacularTitle:泰能和氨苄西林/舒巴坦治疗鲍曼不动杆菌感染的临床研究
- Author:
Qingling ZHANG
;
Minghua LIU
;
Xianyuan WANG
;
Weiling FU
;
- Publication Type:Journal Article
- Keywords:
Acinetobacter baumannii;
infection;
treatment outcome
- From:Journal of Third Military Medical University
2003;0(07):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare treatment outcomes and antibiotic related costs of A. baumannii infection treated with imipenem cilastatin and ampicillin sulbactam and to provide evidence for clinical treatment of A. baumannii infection. Methods A prospective investigation was performed on 71 ICU A. baumannii infection patients treated with imipenem cilastatin and ampicillin sulbactam. The treatment outcomes and antibiotic related costs were also analyzed. Results There was no significant difference between the therapeutic efficacy of these two drugs within the same time limit. The antibiotic related costs of the patients treated with ampicillin sulbactam were significantly lower than those with imipenem cilastatin (2 113 Yuan vs 5 789 Yuan , P
